Legal & General Group’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.6K | Sell |
305
-472
| -61% | -$81.5K | ﹤0.01% | 2704 |
|
|
2025
Q1 | $121K | Sell |
777
-16,905
| -96% | -$2.63M | ﹤0.01% | 2653 |
|
|
2024
Q4 | $2.43M | Buy |
17,682
+16,628
| +1,578% | +$2.29M | ﹤0.01% | 1892 |
|
|
2024
Q3 | $157K | Hold |
1,054
| – | – | ﹤0.01% | 2700 |
|
|
2024
Q2 | $144K | Buy |
1,054
+189
| +22% | +$25.8K | ﹤0.01% | 2704 |
|
|
2024
Q1 | $131K | Buy |
865
+667
| +337% | +$101K | ﹤0.01% | 2721 |
|
|
2023
Q4 | $24.9K | Sell |
198
-840
| -81% | -$106K | ﹤0.01% | 2947 |
|
|
2023
Q3 | $97.2K | Buy |
+1,038
| New | +$97.2K | ﹤0.01% | 2831 |
|